Sr. Director, Asset Lead

Overview

Lantheus (NASDAQ: LNTH) is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and United Kingdom, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. Today, we're expanding our portfolio and pipeline across oncology, neurology and cardiology.

Through recent acquisitions, along with strategic partnerships across the life sciences ecosystem, we are accelerating our efforts to advance precision medicine and improve patient outcomes around the world. At Lantheus we are purpose-driven, and every employee plays a vital role in our success. We're dedicated to cultivating a high-growth, forward-thinking culture where innovation thrives and diverse perspectives drive meaningful progress.

Join us and be part of a company where your contributions make a real impact, because we know someone s health is in our hands.

Summary of role - Lantheus is seeking an Asset Lead with a proven track record in global oncology and/or neurology product development, ideally with experience in developing and launching oncology and/or Alzheimer s assets both in the U.S. and internationally. Reporting to the Head of Asset Leadership, the successful candidate will lead, manage, and communicate on behalf of the cross-functional asset team.

The Asset Lead will serve as the primary point of accountability for the program, interfacing with the executive leadership, and will work closely with the program team to shape and execute the program strategy. The candidate will integrate cross-functional input, synthesize team recommendations, and direct the program to achieve its goals. The candidate will be a highly effective influencer and team player, an excellent communicator, and a driver to effectively achieve program goals.

This position is based in Bedford, MA and requires a presence on-site of three days per week, and is open to applicants authorized to work for any employer within the United States.

Responsibilities

• Forge and lead a high-performing Asset Team, driving cross-functional performance against established objectives.
• Collaborate closely with functional managers to guide the cross-functional team effectively.
• Foster the professional growth and success of team members through mentorship and coaching.
• Develop and refine the asset s global strategy and Target Product Profile in alignment with business objectives.
• Secure approval from governance bodies on strategy, timelines, budget, and risk management, ensuring transparent communication of decisions to governance and the team.
• Align program goals, resources, and expertise to achieve strategic goals and milestones.
• Provide decisive scientific and program leadership expertise.
• Ensure alignment of program activities with strategic priorities, identifying and managing critical path activities, risks, and contingencies.
• Act as the primary liaison between the Asset Team and Executive Leadership, delivering regular One Team Voice updates on progress and risk mitigation plans.
• Drive strategic and tactical planning to inform long-range planning and portfolio prioritization.
• Lead by influence and demonstrate collaborative behaviors to foster cross-functional ways of working, with teams and functions.
• Govern the meeting structures within the team: assign subteams and subteam membership from team subject matter experts (SMEs) to facilitate efficient use of SME time.
• Ensure best meeting practices, including balancing preparation with SME time and circulating brief minutes of decisions and actions following important meetings.

Basic Qualifications

• Advanced or professional degree highly desirable (e.g., PhD, MD, or MBA)
• 15+ years of industry experience with 10+ years of drug development and leadership experience
• Proven track record in leading cross-functional asset teams supporting early- and late-stage programs through regulatory milestones (NDA/BLA), life cycle management and geographical expansion.
• Comprehensive understanding of drug development…